Senores Pharmaceuticals Limited — Pledging, 17-02-2026: Pledge/Unpledge

Senores Pharmaceuticals promoter group entity, Espee Therapeutics LLP, has pledged 400,000 equity shares with Bajaj Finance Limited. This represents 0.87% of Senores Pharma's total share capital. Notably, these pledged shares constitute approximately 80.8% of Espee Therapeutics LLP's total holding of 4.95 lakh shares in the company. The pledge acts as collateral for a loan taken by Renosen Pharmaceuticals Private Limited, another entity within the promoter group. For investors, share pledging can indicate leveraging by the promoter group and introduces risk, as these shares could be invoked by the lender if the underlying loan defaults.